We are live on ! Find out more
GEN

Genesis Healthcare, Inc.
GEN

Delisted

GEN was delisted on the 25th of March, 2021.

58 hedge funds and large institutions have $18.1M invested in Genesis Healthcare, Inc. in 2020 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 11 increasing their positions, 17 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% less funds holding

Funds holding: 6758 (-9)

35% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 17

36% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 25

38% less capital invested

Capital invested by funds: $29.1M → $18.1M (-$11M)

Holders
58
Holders Change
-9
Holders Change %
-13.43%
% of All Funds
1.19%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
16
Increased
11
Reduced
17
Closed
25
Calls
$5K
Puts
Net Calls
+$5K
Net Calls Change
-$2K
Name Holding Trade Value Shares
Change
Change in
Stake
BPA
26
Beacon Pointe Advisors
California
$55K +$64.1K +79,750 New
RJA
27
Raymond James & Associates
Florida
$38K
JP Morgan Chase
28
JP Morgan Chase
New York
$35K -$211K -263,019 -84%
HF
29
HRT Financial
New York
$34K +$40.4K +50,255 New
APG
30
Abacus Planning Group
South Carolina
$28K
Morgan Stanley
31
Morgan Stanley
New York
$28K +$16.1K +19,969 +97%
LP
32
LMR Partners
United Kingdom
$27K +$31.6K +39,285 New
BNP Paribas Financial Markets
33
BNP Paribas Financial Markets
France
$26K +$9.43K +11,723 +45%
TRCT
34
Tower Research Capital (TRC)
New York
$25K +$21.2K +26,344 +270%
State Street
35
State Street
Massachusetts
$24K -$1.01M -1,258,779 -97%
Charles Schwab
36
Charles Schwab
California
$23K -$142K -176,810 -84%
GCP
37
GSA Capital Partners
United Kingdom
$16K +$18.5K +22,972 New
Bank of New York Mellon
38
Bank of New York Mellon
New York
$15K -$160K -198,502 -90%
Citigroup
39
Citigroup
New York
$14K -$18.4K -22,907 -53%
TA
40
Teton Advisors
New York
$14K -$4.02K -5,000 -20%
DC
41
Diametric Capital
Massachusetts
$13K +$14.6K +18,121 New
VF
42
Virtu Financial
New York
$13K +$14.6K +18,173 New
WP
43
WMS Partners
Maryland
$12K
Janus Henderson Group
44
Janus Henderson Group
United Kingdom
$11K -$1.55K -1,929 -10%
SEI Investments
45
SEI Investments
Pennsylvania
$9K
BCM
46
Bayesian Capital Management
New York
$9K +$10.3K +12,832 New
Victory Capital Management
47
Victory Capital Management
Texas
$8K -$9.61K -11,948 -51%
Royal Bank of Canada
48
Royal Bank of Canada
Ontario, Canada
$8K +$5.28K +6,565 +149%
PCM
49
Prelude Capital Management
New York
$8K +$9.9K +12,314 New
SIM
50
Spark Investment Management
New York
$7K

GEN Hedge Fund Activity: Q2 2020 in Review

58 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Genesis Healthcare, Inc. (GEN) for Q2 2020, worth a combined $18.1M — down 38% from $29.1M a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of GEN and 16 opened new positions — a net loss of 9 holders — while 17 trimmed existing stakes and 11 added.

The largest buyer was Vanguard Group, adding an estimated $1.32M. The largest seller was BlackRock, cutting an estimated $3.2M.

  • 58 institutional investors held Genesis Healthcare, Inc. (GEN) as of Q2 2020, down from 67 in Q1 2020.
  • Funds reported $18.1M of Genesis Healthcare, Inc. stock for Q2 2020, down 38% quarter-over-quarter.
  • 16 funds opened new Genesis Healthcare, Inc. positions in Q2 2020 and 25 closed out, a net change of -9 holders.
  • The largest Genesis Healthcare, Inc. buyer in Q2 2020 was Vanguard Group, an estimated $1.32M added.
  • The largest Genesis Healthcare, Inc. seller in Q2 2020 was BlackRock, an estimated $3.2M sold.

Based on aggregated 13F filings for Q2 2020.